Similar articles

• Virus-specific T cells as correlate of (cross-)protective immunity against influenza.

  Altenburg AF, Rimmelzwaan GF, de Vries RD. Altenburg AF, et al. Vaccine. 2015 Jan 15;33(4):500-6. doi: 10.1016/j.vaccine.2014.11.054. Epub 2014 Dec 9. Vaccine. 2015. PMID: 25498210 Review.
• Some newly recognized aspects of resistance against and recovery from influenza.

  Ennis A. Ennis A. Arch Virol. 1982;73(3-4):207-17. doi: 10.1007/BF01318075. Arch Virol. 1982. PMID: 6816194 Review. No abstract available.
• Gene cloning to study viral antigens: prospects for novel influenza and rotavirus vaccines.

  Both GW, Jennings PA. Both GW, et al. Prog Vet Microbiol Immunol. 1987;3:179-213. Prog Vet Microbiol Immunol. 1987. PMID: 2856220 Review. No abstract available.
• The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes.

  Budimir N, Meijerhof T, Wilschut J, Huckriede A, de Haan A. Budimir N, et al. Vaccine. 2010 Dec 6;28(52):8280-7. doi: 10.1016/j.vaccine.2010.10.007. Epub 2010 Oct 19. Vaccine. 2010. PMID: 20965298
• Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies.

  Lafont BAP, Bennink JR. Lafont BAP, et al. Viral Immunol. 2020 Apr;33(3):197-200. doi: 10.1089/vim.2019.0167. Viral Immunol. 2020. PMID: 32286176 Free PMC article. No abstract available.